The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infection: A meta‐analysis and meta‐regression†
Open accessAbstract
UNLABELLED: Published estimates of liver fibrosis progression in individuals with chronic hepatitis C virus (HCV) infection are heterogeneous. We aimed to estimate stage-specific fibrosis progression rates and their determinants in these individuals. A systematic review of published prognostic studies was undertaken. Study inclusion criteria were as follows: (1) presence of HCV infection determined by serological assays; (2) available information about age at assessment of liver disease or HCV acquisition; (3) duration of HCV infection; and (4) histological and/or clinical diagnosis of cirrhosis. Annual stage-specific transition probabilities (F0-->F1, ... , F3-->F4) were derived using the Markov maximum likelihood estimation method and a meta-analysis was performed. The impact of potential covariates was evaluated using meta-regression. A total of 111 studies of individuals with chronic HCV infection (n = 33,121) were included. Based on the random effects model, the estimated annual mean (95% confidence interval) stage-specific transition probabilities were: F0-->F1 0.117 (0.104-0.130); F1-->F2 0.085 (0.075-0.096); F2-->F3 0.120 (0.109-0.133); and F3-->F4 0.116 (0.104-0.129). The estimated prevalence of cirrhosis at 20 years after the infection was 16% (14%-19%) for all studies, 18% (15%-21%) for cross-sectional/retrospective studies, 7% (4%-14%) for retrospective-prospective studies, 18% (16%-21%) for studies conducted in clinical settings, and 7% (4%-12%) for studies conducted in nonclinical settings. Duration of infection was the most consistent factor significantly associated with progression of fibrosis. CONCLUSION: Our large systematic review provides increased precision in estimating fibrosis progression in chronic HCV infection and supports nonlinear disease progression. Estimates of progression to cirrhosis from studies conducted in clinical settings were lower than previous estimates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Advanced methods in meta‐analysis: multivariate approach and meta‐regression
van Houwelingen, H. C., Arends, L. R., & Stijnen, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1040 · Cited by 1,580
Classification of chronic viral hepatitis: a need for reassessment
Scheuer, P. J. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90084-o · Cited by 1,576
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P., Katlama, C., et al. (1999) · Hepatology · doi:10.1002/hep.510300409 · Cited by 1,219
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
An Update on Terminology and Reporting
Batts, K. P., & Ludwig, J. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199512000-00007 · Cited by 1,080
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Conry-Cantilena, C., VanRaden, M., Gibble, J., Melpolder, J., Shakil, A. O., Viladomiu, L., Cheung, L., DiBisceglie, A., Hoofnagle, J., Shih, J. W., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342602 · Cited by 627
Estimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620
Self-citationLong-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Natural history of hepatitis C
Seeff, L. B. (1997) · Hepatology · doi:10.1002/hep.510260704 · Cited by 409
Progression of fibrosis in chronic hepatitis C
Ghany, M. G., Kleiner, D. E., Alter, H., Doo, E., Khokar, F., Promrat, K., Herion, D., Park, Y., Liang, T. J., & Hoofnagle, J. H. (2003) · Gastroenterology · doi:10.1053/gast.2003.50018 · Cited by 403
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
Di Martino, V., Lebray, P., Myers, R. P., Pannier, E., Paradis, V., Charlotte, F., Moussalli, J., Thabut, D., Buffet, C., & Poynard, T. (2004) · Hepatology · doi:10.1002/hep.20463 · Cited by 280
High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus
Esteban, R., López-Talavera, J. C., Genescà, J., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-443 · Cited by 279
Ryder, S. D. (2004) · Gut · doi:10.1136/gut.2003.021691 · Cited by 276
Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis
Tremolada, F., Casarin, C., Alberti, A., Drago, C., Tagger, A., Ribero, M. L., & Realdi, G. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80657-9 · Cited by 263
Sobesky, R., Mathurin, P., Charlotte, F., Moussalli, J., Olivi, M., Vidaud, M., Ratziu, V., Opolon, P., & Poynard, T. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70135-6 · Cited by 252
Bonacini, M., Hadi, G., Govindarajan, S., & Lindsay, K. L. (1997) · PubMed · Cited by 250
Schmid, C. H., Stark, P. C., Berlin, J. A., Landais, P., & Lau, J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.12.001 · Cited by 245
The natural course of chronic hepatitis C
Iwarson, S. (1994) · FEMS Microbiology Reviews · doi:10.1016/0168-6445(94)90033-7 · Cited by 238
Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade
Koretz, R. L., Abbey, H., Coleman, E., & Gitnick, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00003 · Cited by 233
Puoti, M., Bonacini, M., Spinetti, A., Putzolu, V., Govindarajan, S., Zaltron, S., Favret, M., Callea, F., Gargiulo, F., Donato, F., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/317644 · Cited by 195
Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study
Wiese, M., Grüngreiff, K., Güthoff, W., Lafrenz, M., Oesen, U., & Porst, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.007 · Cited by 187
The nomenclature of chronic active hepatitis: An obituary
Ludwig, J. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90037-d · Cited by 185
Which patients with hepatitis C develop liver complications?
Khan, M. H., Farrell, G. C., Byth, K., Lin, R., Weltman, M., George, J., Samarasinghe, D., Kench, J., Kaba, S., Crewe, E., et al. (2000) · Hepatology · doi:10.1002/hep.510310236 · Cited by 160
Empirically Calibrated Model of Hepatitis C Virus Infection in the United States
Salomon, J. A. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf100 · Cited by 130
NON-A, NON-B POST-TRANSFUSION HEPATITIS
Dienstag, J. L., Purcell, R., Alter, H. J., et al. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91996-1 · Cited by 126
Fibrosis in Chronic Hepatitis C Acquired in Infancy: Is It Only a Matter of Time?
Guido, M., Bortolotti, F., Leandro, G., Jara, P., Hierro, L., Larrauri, J., Barbera, C., Giacchino, R., Zancan, L., Balli, F., et al. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)06015-x · Cited by 126
Epidemiology and long term prognosis of hepatitis C virus infection in Japan.
Yano, M., Yatsuhashi, H., INOUE, O., Inokuchi, K., & Koga, M. (1993) · Gut · doi:10.1136/gut.34.2_suppl.s13 · Cited by 125
Natural History of Hepatitis C Virus-Related Liver Fibrosis After Renal Transplantation
Kamar, N., Rostaing, L. P. E., Sèlves, J., Sauné, K., Alric, L., DurandAlric, D., & Izopet, J. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00918.x · Cited by 123
HISTOPATHOLOGICAL FEATURES OF HEPATITIS C IN RENAL TRANSPLANT CANDIDATES1
Martin, P., Carter, D., Fabrizi, F., Dixit, V., Conrad, A. J., Artinian, L., Peacock, V., Han, S. H., Wilkinson, A. H., Lassman, C., et al. (2000) · Transplantation · doi:10.1097/00007890-200004150-00045 · Cited by 118
Progression of liver fibrosis among injection drug users with chronic hepatitis C†
Wilson, L. E., Torbenson, M. S., Astemborski, J. A., Faruki, H., Spoler, C., Rai, R., Mehta, S. H., Kirk, G. D., Nelson, K. E., Afdhal, N. H., et al. (2006) · Hepatology · doi:10.1002/hep.21091 · Cited by 111
Mattsson, L., Sönnerborg, A. B., & Weiland, O. (1993) · Liver International · doi:10.1111/j.1600-0676.1993.tb00644.x · Cited by 108
Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C†
Saadoun, D., Asselah, T., Resche‐Rigon, M., Charlotte, F., Bédossa, P., Valla, D. C., Pietté, J. C., Marcellin, P., & Cacoub, P. (2006) · Hepatology · doi:10.1002/hep.21190 · Cited by 92
Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children
Mohan, P., Colvin, C. A., Glymph, C., Chandra, R. R., Kleiner, D. E., Patel, K. M., Luban, N. L. C., & Alter, H. J. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.11.037 · Cited by 90
Datz, C., Cramp, M., Haas, T., Dietze, O., Nitschko, H., Froesner, G., Muss, N., Sandhofer, F., & Vogel, W. (1999) · Gut · doi:10.1136/gut.44.4.563 · Cited by 79
Hepatitis C in the General Adult Population of Oslo: Prevalence and Clinical Spectrum
Dalgård, O., Jeansson, S. L., Skaug, K., Raknerud, N., & Bell, H. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310004542 · Cited by 78
Severity and correlates of liver disease in hepatitis C virus-infected injection drug users
Rai, R., Wilson, L. E., Astemborski, J. A., Anania, F. A., Torbenson, M. S., Spoler, C., Vlahov, D., Strathdee, S. A., Boitnott, J., Nelson, K. E., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.33151 · Cited by 73
Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model
Deuffic‐Burban, S., Poynard, T., & Valleron, A. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00340.x · Cited by 71
Hamada, H., Yatsuhashi, H., Yano, K., Daikoku, M., Arisawa, K., INOUE, O., Koga, M., Nakata, K., Eguchi, K., & Yano, M. (2002) · Cancer · doi:10.1002/cncr.10662 · Cited by 65
Sweeting, M. J., Angelis, D. D., Neal, K. R., Ramsay, M. E., Irving, W. L., Wright, M., Brant, L. J., & Harris, H. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.06.008 · Cited by 63
Verma, S., Bonacini, M., Govindarajan, S., Kanel, G. C., Lindsay, K. L., & Redeker, A. G. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00682.x · Cited by 60
Shin, J. L., Teitel, J. M., Swain, M. G., Bain, V. G., Adams, P. C., Croitoru, K., Peltekian, K. M., Schweiger, F., Simons, M. E., & Heathcote, E. J. (2005) · American Journal of Hematology · doi:10.1002/ajh.20263 · Cited by 55
Improving the accuracy of long‐term prognostic estimates in hepatitis C virus infection
Yi, Q., Wang, P., & Krahn, M. D. (2004) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00484.x · Cited by 52
Self-citationLevine, R. A., Sanderson, S. O., Ploutz-Snyder, R. J., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.028 · Cited by 49
HEPATITIS C VIRUS AND LIVER TRANSPLANTATION
Ahmed, A., & Keeffe, E. B. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70210-5 · Cited by 48
Serra, M. Á., Rodríguez, F. G., del Olmo, J. A., Escudero, A., & Rodrigo, J. M. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00372.x · Cited by 47
Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus
Irving, W. L., Neal, K. R., Underwood, J. C. E., Peter Simmonds, K., & James, V. (1994) · BMJ · doi:10.1136/bmj.308.6930.695 · Cited by 35
Importance of age in chronic hepatitis C virus infection
Wong, V., Caronia, S., Wight, D. G. D., Palmer, C., Petrík, J., Britton, P. D., & Alexander, G. (1997) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1997.00054.x · Cited by 33
Gruber, A., Norder, H., Magnius, L. O., Rotzén, M., Rubio‐Terres, C., Grillner, L., & Björkholm, M. (1993) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058462 · Cited by 23
Albloushi, S. S., Murray, F. E., Callagy, G. M., et al. (1998) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199801000-00013 · Cited by 18
Guido, M., Franceschi, L. D., Olivari, N., Leandro, G., Felder, M., Corrocher, R., Rugge, M., Pasino, M., Lanza, C., Capelli, P., et al. (2006) · Modern Pathology · doi:10.1038/modpathol.3800592 · Cited by 17
Cited by
Natural history of hepatitis C.
Westbrook, R. H., & Dusheiko, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.012 · Cited by 1,049
Epidemiology and natural history of HCV infection
Hajarizadeh, B., Grebely, J., & Dore, G. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.107 · Cited by 994
Self-citationConti, F., Buonfiglioli, F., Scuteri, A., Crespi, C., Bolondi, L., Caraceni, P., Foschi, F. G., Lenzi, M., Mazzella, G., Verucchi, G., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.015 · Cited by 897
Davis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 878
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.003 · Cited by 855
Metadata
- Authors
- Thein, H., Yi, Q., Dore, G. J., & Krahn, M. D.
- Venue
- Hepatology
- Published
- 2008-08
- Volume
- 48
- Issue
- 2
- Pages
- 418-431
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1984413237
- Cited by
- 829
- References
- 61
- FWCI
- 18.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.